Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House passes limited medical-cannabis policy; companion cultivation bill fails
Summary
On Feb. 9 the House approved a third substitute for HB195 to allow physician-recommended, standardized cannabis-based medicines for terminally ill patients; a companion bill (HB197) to authorize in-state cultivation for research and Right-to-Try failed on a close vote.
The Utah House on Feb. 9 passed a third substitute of House Bill 195, authorizing tightly controlled access to cannabis-based medicines for patients a physician reasonably believes are terminally ill. Representative Doff, who moved the substitute under the name of Representative Dawe, said the change narrows the definition of "terminally ill" and restricts recommendations to physicians only. "It tightens up the definition of what 'terminally ill' means and, also, allows only physicians to do the recommending," Doff said on the floor.
The bill limits the forms that may be dispensed to non-smokeable, medicinal formulations — pills, gels, transdermals or oils —…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
